- Home
- RLMD vs GCMG Comparison
RLMD vs GCMG Comparison
Compare RLMD & GCMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RLMD | GCMG |
|---|---|---|
| Founded | 2004 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 784.6M | 731.1M |
| IPO Year | 2012 | N/A |
Fundamental Metrics
Financial Performance| Metric | RLMD | GCMG |
|---|---|---|
| Price | $7.07 | $10.86 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | $12.40 | ★ $14.33 |
| AVG Volume (30 Days) | ★ 1.4M | 421.9K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.44% |
| EPS Growth | ★ 45.28 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $13,070.00 | N/A |
| Revenue This Year | N/A | $7.28 |
| Revenue Next Year | N/A | $11.70 |
| P/E Ratio | ★ N/A | $28.21 |
| Revenue Growth | ★ 154.83 | N/A |
| 52 Week Low | $0.27 | $9.30 |
| 52 Week High | $7.94 | $13.22 |
Technical Indicators
Market Signals| Indicator | RLMD | GCMG |
|---|---|---|
| Relative Strength Index (RSI) | 55.77 | 58.51 |
| Support Level | $3.49 | $10.35 |
| Resistance Level | $7.41 | $11.88 |
| Average True Range (ATR) | 0.44 | 0.32 |
| MACD | -0.07 | 0.16 |
| Stochastic Oscillator | 35.01 | 82.00 |
Price Performance
Historical ComparisonAbout RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.
About GCMG GCM Grosvenor Inc.
GCM Grosvenor Inc is a world-wide alternative asset management firm. It invests on behalf of clients who seek allocations to alternative investments, such as private equity, infrastructure, real estate, credit, ESG and absolute return strategies. Company invest maximum in Private Equity. The company's offerings include multi-manager portfolios as well as portfolios of direct investments and co-investments.